canin
respiratori
diseas
commonli
seen
dog
along
coinfect
multipl
respiratori
pathogen
includ
virus
bacteria
viru
infect
even
vaccin
dog
also
report
clinic
sign
caus
differ
respiratori
etiolog
agent
similar
make
differenti
diagnosi
imper
oligonucleotid
microarray
system
develop
studi
wild
type
vaccin
strain
canin
distemp
viru
cdv
influenza
viru
canin
herpesviru
chv
bordetella
bronchiseptica
mycoplasma
cyno
detect
differenti
simultan
microarray
chip
detect
limit
copi
number
cdv
influenza
viru
chv
b
bronchiseptica
cyno
respect
clinic
test
result
nasal
swab
sampl
show
microarray
remark
better
efficaci
multiplex
pcragaros
gel
method
posit
detect
rate
microarray
agaros
gel
n
n
among
sampl
respect
cdv
vaccin
strain
pathogen
coinfect
demonstr
microarray
multiplex
pcragaros
gel
oligonucleotid
microarray
provid
highli
effici
diagnosi
altern
could
appli
clinic
usag
greatli
assist
diseas
therapi
control
respiratori
infect
common
problem
dog
mochizuki
et
al
etiolog
agent
involv
canin
infecti
respiratori
diseas
complex
viral
infecti
agent
includ
canin
distemp
viru
cdv
influenza
viru
canin
herpesviru
chv
canin
adenoviru
canin
parainfluenza
viru
cpiv
canin
respiratori
coronaviru
crcov
jeoung
et
al
bordetella
bronchiseptica
mycoplasma
cyno
signific
bacteri
etiolog
agent
mochizuki
et
al
priestnal
et
al
canin
distemp
cd
highli
contagi
fatal
diseas
dog
caus
cdv
cdv
belong
paramyxovirida
famili
although
live
attenu
vaccin
use
mani
year
control
distemp
cdv
continu
caus
outbreak
particularli
young
dog
demet
et
al
previou
studi
report
vaccin
dog
infect
cdv
mexico
japan
simonmartinez
et
al
uema
et
al
therefor
necessari
discrimin
wild
type
vaccin
type
strain
attenu
cdv
vaccin
use
worldwid
hemagglutinin
h
gene
reveal
pronounc
genet
divers
employ
detect
differenti
differ
cdv
strain
si
et
al
uema
et
al
specif
therapi
anim
canin
distemp
besid
support
treatment
deem
et
al
influenza
viru
belong
famili
orthomyxovirida
matrix
gene
highli
conserv
often
use
viru
detect
fouchier
et
al
influenza
viru
caus
sustain
transmiss
among
dog
lead
respiratori
diseas
outbreak
eg
crawford
et
al
payungporn
et
al
song
et
al
treatment
antivir
medicin
oseltamivir
approv
human
use
dog
still
need
evalu
beeler
canin
herpesviru
chv
member
herpesvirida
famili
infect
older
dog
appear
restrict
upper
respiratori
tract
buonavoglia
martella
chv
glycoprotein
b
gene
often
use
viru
detect
target
highli
conserv
decaro
et
al
limit
studi
antivir
agent
vidarabin
inconclus
immedi
recognit
treatment
essenti
possibl
success
creevi
june
tion
hozbor
et
al
b
bronchiseptica
strain
sensit
aminoglycosid
extendedspectrum
third
gener
penicillin
tetracyclin
quinolon
trimethoprimsulfamethoxazol
mattoo
cherri
mycoplasma
cyno
demonstr
mollicut
found
associ
canin
infecti
respiratori
diseas
pcr
detect
develop
base
rrna
intergen
spacer
ig
chalker
treatment
none
antibiot
doxycyclin
tetracyclin
effect
canin
mycoplasma
chalker
infect
mix
respiratori
pathogen
dog
commonli
seen
clinic
sign
similar
make
differenti
diagnosi
necessari
chvala
et
al
erl
et
al
jeoung
et
al
mochizuki
et
al
simultan
canin
vurial
respiratori
diseas
detect
use
multiplex
pcr
report
jeoung
et
al
etiogen
bacteria
involv
wild
vaccin
type
cdv
could
distinguish
microarray
promis
altern
detect
hundr
thousand
gene
parallel
studi
attempt
develop
oligonucleotid
microarray
system
simultan
detect
differenti
dog
respiratori
pathogen
includ
wild
strain
vaccin
strain
cdv
influenza
viru
chv
b
bronchiseptica
mcyno
pathogen
chosen
base
diseas
fatal
particular
medicin
option
oligonucleotid
microarray
could
provid
excel
diagnosi
approach
better
efficaci
effici
comprehens
distinguish
clinic
signific
dog
respiratori
pathogen
includ
virus
bacteria
time
propos
devic
might
greatli
assist
diseas
control
therapi
flow
chart
experiment
design
shown
supplement
fig
nucleic
acid
refer
pathogen
clinic
sampl
includ
dna
rna
extract
use
petnad
tm
nucleic
acid
coprep
kit
genereach
biotechnolog
corp
taiwan
accord
manufactur
instruct
rna
revers
transcrib
dna
use
transcriptor
high
fidel
cdna
synthesi
kit
roch
mannheim
germani
base
manufactur
instruct
pcr
primer
origin
modif
publish
one
target
gene
cdv
civ
chv
b
bronchiseptica
cyno
hemagglutinin
gene
matrix
gene
glycoprotein
b
gene
flagellin
gene
rrna
ig
region
respect
tabl
uniplex
pcr
carri
reaction
volum
l
contain
l
templat
l
primer
l
taq
master
mix
protech
taipei
taiwan
amplif
thermal
profil
pathogen
describ
cdv
c
min
c
c
c
c
min
civ
c
min
c
min
c
min
c
min
c
min
chv
c
min
c
c
c
c
min
b
bronchiseptica
c
min
c
min
c
c
c
min
cyno
c
min
c
min
c
c
min
c
min
ten
l
pcr
product
separ
agaros
gel
run
ml
tbe
buffer
l
mgml
ethidium
bromid
v
min
visual
uv
light
dna
refer
pathogen
clinic
sampl
subject
multiplex
pcr
whose
reaction
solut
prepar
uniplex
pcr
except
five
pair
primer
endbiotinyl
employ
time
multiplex
pcr
thermal
profil
c
min
c
c
c
c
min
ten
l
pcr
product
separ
agaros
gel
run
ml
tbe
buffer
l
mgml
ethidium
bromid
v
min
visual
uv
light
microarray
gener
probe
use
detect
pathogen
design
base
conserv
sequenc
within
amplicon
amplifi
pair
primer
probe
use
differenti
differ
cdv
type
design
base
amplicon
sequenc
differ
among
differ
type
probe
deriv
align
analys
nucleotid
sequenc
retriev
genbank
conduct
use
megalign
program
dnastar
madison
wi
probe
sequenc
target
strain
list
tabl
tail
compos
base
ad
onto
oligonucleotid
probe
includ
posit
control
probe
oligonucleotid
capsid
protein
human
enteroviru
gene
enhanc
cohes
strength
probe
microarray
substrat
twenti
probe
spot
specif
posit
microarray
polym
substrat
use
dr
easi
spotter
dr
chip
biotech
miaoli
taiwan
immobil
use
stratagen
uv
stratalink
stratagen
santa
clara
ca
j
hybrid
reaction
dna
templat
probe
carri
dr
chip
diy
tm
kit
dr
chip
biotech
miaoli
taiwan
multiplex
pcr
product
denatur
c
min
cool
ice
bath
min
microarray
chamber
ad
l
hybrid
buffer
contain
endbiotinyl
oligonucleotid
complementari
posit
control
probe
sequenc
two
l
denatur
multiplex
pcr
prod
uct
ad
incub
c
vibrat
h
sampl
wash
twice
l
wash
buffer
room
temperatur
block
reaction
perform
mix
l
streptavidin
conjug
alkalin
phosphatas
l
block
reagent
room
temperatur
min
follow
wash
twice
wash
buffer
colorimetr
reaction
implement
ad
l
nbtbcip
l
detect
buffer
chamber
develop
dark
room
temperatur
min
wash
twice
distil
water
hybrid
result
read
directli
nake
eye
uniplex
pcr
posit
signal
band
agaros
gel
extract
purifi
use
genephlow
tm
gelpcr
kit
geneaid
new
taipei
citi
taiwan
clone
pgemt
easyvector
system
promega
madison
wi
follow
manufactur
instruct
plasmid
transform
max
chemic
compet
e
coli
invitrogen
carlsbad
ca
cultur
lb
agar
becton
dickson
compani
spark
md
coloni
success
insert
confirm
pcr
use
plasmid
primer
amplifi
lb
broth
becton
dickson
compani
spark
md
plasmid
dna
extract
use
mini
plu
tm
plasmid
dna
extract
system
viogen
shijr
taiwan
insert
sequenc
use
commerci
servic
mission
biotech
taipei
taiwan
obtain
sequenc
check
use
blast
http
blastncbinlmnihgovblastcgi
confirm
nucleotid
correct
plasmid
dna
chv
b
bronchiseptica
cyno
quantifi
spectrophotomet
genequ
ii
pharmacia
uppsala
sweden
dna
copi
number
calcul
dna
dilut
serial
te
buffer
multiplex
pcr
templat
plasmid
dna
cdv
civ
linear
restrict
enzym
saci
new
england
biolab
ipswich
convers
dna
polymeras
klenow
promega
madison
wi
vitro
transcript
perform
use
riboprob
vitro
transcript
system
promega
madison
wi
rna
polymeras
accord
manufactur
recommend
remain
dna
remov
use
rnasefre
dnase
promega
madison
wi
viral
rna
quantifi
use
spectrophotomet
genequ
ii
pharmacia
uppsala
sweden
copi
number
calcul
rna
serial
dilut
depc
treat
water
use
templat
follow
revers
transcript
multiplex
pcr
agaros
gel
oligonucleotid
microarray
detect
limit
compar
pairedsampl
ttest
use
evalu
differ
agaros
gel
microarray
clinic
sampl
use
spss
ibm
corp
ny
usa
uniplex
pcr
could
specif
amplifi
target
pathogen
show
correspond
band
gel
supplement
fig
multiplex
pcr
success
develop
anneal
temperatur
c
product
size
civ
b
bronchiseptica
chv
cyno
cdv
bp
bp
bp
bp
bp
respect
crcov
amplifi
expect
fig
differ
strain
cdv
could
distinguish
gel
dog
respiratori
pathogen
test
use
oligonucleotid
microarray
follow
multiplex
pcr
pathogen
unambigu
detect
differenti
crossreact
found
among
nonrel
probe
fig
wild
type
vaccin
type
cdv
also
well
distinguish
crcov
nasal
swab
sampl
healthi
dog
employ
neg
control
result
indic
good
detect
specif
among
select
pathogen
normal
nasal
flora
would
bring
nonspecif
microarray
signal
detect
limit
result
agaros
gel
microarray
multiplex
pcr
shown
fig
gel
detect
limit
cdv
wild
type
strain
civ
chv
b
bronchiseptica
cyno
copi
number
respect
microarray
detect
limit
cdv
wild
type
strain
civ
chv
b
bronchiseptica
cyno
copi
number
respect
cdv
vaccin
strain
includ
probe
target
onderstepoort
distemperoid
lederl
ba
strain
probe
target
ncdv
strain
display
detect
limit
result
wild
strain
data
shown
fiftysix
nasal
swab
sampl
dog
show
respiratori
sign
test
use
oligonucleotid
microarray
multiplex
pcr
agaros
gel
result
compar
concurr
tabl
agaros
gel
microarray
detect
result
certain
repres
sampl
shown
supplement
fig
detect
posit
rate
microarray
agaros
gel
n
n
respect
frequenc
posit
result
statist
differ
two
method
p
valu
oligonucleotid
microarray
show
exceed
differenti
effect
one
sampl
differenti
cdv
tradit
vaccin
strain
among
total
singl
cdv
infect
posit
sampl
coinfect
cdv
influenza
viru
cdv
chv
cdv
b
bronchiseptica
demonstr
microarray
none
reveal
agaros
gel
clinic
sign
caus
respiratori
pathogen
includ
virus
bacteria
similar
coinfect
multipl
pathogen
also
frequent
seen
erl
et
al
jeoung
et
al
make
differenti
diagnosi
imper
enact
correct
treatment
introduct
live
attenu
cdv
vaccin
extens
marker
copi
copi
copi
copi
copi
copi
use
drastic
reduc
cd
incid
dog
howev
cd
outbreak
involv
virul
virus
introduc
partli
immun
popul
still
observ
iwatsuki
et
al
radtanakatikanon
et
al
differenti
wild
type
vaccin
type
cd
necessari
perform
cdv
detect
simonmartinez
et
al
wang
et
al
base
cdv
h
gene
align
analysi
cdv
vaccin
avail
taiwan
cdv
vaccin
strain
could
divid
two
group
tradit
vaccin
group
onderstepoort
strain
distemperoid
strain
lederl
strain
ba
strain
contemporari
vaccin
group
ncdv
strain
high
homolog
vaccin
x
chulakasian
et
al
three
canin
respiratori
virus
cdv
crcov
influenza
viru
report
distinguish
use
multiplex
pcr
jeoung
et
al
four
canin
respiratori
rna
virus
two
dna
virus
report
detect
use
multiplex
rtpcr
multiplex
pcr
respect
piewbang
et
al
wild
type
tradit
cdv
vaccin
strain
could
discrimin
use
pcrrestrict
fragment
length
polymorph
wang
et
al
zhao
et
al
cotemporari
vaccin
strain
abl
distinguish
use
refractori
mutat
systempcr
amplif
chulakasian
et
al
howev
comprehens
integr
approach
ever
develop
herein
oligonucleotid
microarray
system
develop
simultan
detect
differenti
clinic
canin
signific
respiratori
pathogen
includ
virus
bacteria
tradit
contemporari
cdv
vaccin
strain
microarray
signal
easili
read
nake
eye
requir
addit
reader
equip
detect
limit
comparison
clinic
sampl
test
find
demonstr
microarray
higher
effici
sensit
multiplex
pcragaros
gel
method
microarray
cdv
detect
limit
viral
copi
even
lower
copi
use
cdv
heminest
rtpcr
di
francesco
et
al
although
real
time
rtpcr
achiev
similar
low
detect
limit
respiratori
pathogen
aeschbach
et
al
decaro
et
al
nummi
et
al
tatti
et
al
wilk
et
al
machin
cost
high
microarray
present
studi
compar
real
time
rtpcr
could
feasibl
altern
especi
prefer
local
underequip
laboratori
microarray
specif
also
prove
crossreact
signal
observ
among
unrel
probe
tradit
approach
agaros
gel
band
need
cut
sequenc
confirm
doubt
result
howev
microarray
accuraci
could
ensur
omit
step
sinc
complementari
templateprob
sequenc
hybrid
produc
posit
signal
although
electrophoresi
cost
usd
might
increas
usd
sequenc
need
differenti
compar
microarray
cost
usd
array
reusabl
follow
gel
imag
equip
sequenc
demand
time
cost
sampl
receipt
microarray
readout
h
howev
would
take
day
use
tradit
method
sequenc
also
includ
probe
design
cdv
wild
type
strain
taiwan
japan
south
korea
china
probe
japan
south
korea
china
bind
howev
could
test
studi
sinc
foreign
strain
avail
taiwan
experi
would
need
efficaci
verif
microarray
clinic
sampl
test
cdv
influenza
viru
chv
b
bronchiseptica
detect
nasal
swab
sampl
none
cyno
captur
might
due
sampl
method
cyno
lower
respiratori
tract
detect
rate
cyno
might
higher
sampl
taken
lower
respiratori
tract
eg
bronchialalveolar
lavag
rna
virus
would
constant
mutat
time
microarray
efficaci
might
decreas
mutat
occur
primer
probe
site
howev
microarray
function
could
extend
recruit
new
probe
would
make
devic
applic
meet
futur
practic
need
